Veitinger Klaus R Dr - Net Worth and Insider Trading

Veitinger Klaus R Dr Net Worth

The estimated net worth of Veitinger Klaus R Dr is at least $127,912 dollars as of 2024-11-13. Veitinger Klaus R Dr is the Director of Relypsa Inc and owns about 2,712 shares of Relypsa Inc (RLYP) stock worth over $86,757. Veitinger Klaus R Dr is the Director of Intercept Pharmaceuticals Inc and owns about 2,166 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $41,154. Veitinger Klaus R Dr is also the Director of Tricida Inc and owns about 144,203 shares of Tricida Inc (TCDAQ) stock worth over $1. Details can be seen in Veitinger Klaus R Dr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Veitinger Klaus R Dr has not made any transactions after 2019-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Veitinger Klaus R Dr

To

Veitinger Klaus R Dr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Veitinger Klaus R Dr owns 4 companies in total, including Tricida Inc (TCDAQ) , scPharmaceuticals Inc (SCPH) , and Intercept Pharmaceuticals Inc (ICPT) among others .

Click here to see the complete history of Veitinger Klaus R Dr’s form 4 insider trades.

Insider Ownership Summary of Veitinger Klaus R Dr

Ticker Comapny Transaction Date Type of Owner
TCDAQ Tricida Inc 2019-11-01 director
SCPH scPharmaceuticals Inc 2017-11-21 director
ICPT Intercept Pharmaceuticals Inc 2015-11-10 director
LIMIT LIMIT 2015-05-11 director

Veitinger Klaus R Dr Latest Holdings Summary

Veitinger Klaus R Dr currently owns a total of 3 stocks. Among these stocks, Veitinger Klaus R Dr owns 2,712 shares of Relypsa Inc (RLYP) as of May 11, 2015, with a value of $86,757 and a weighting of 67.83%. Veitinger Klaus R Dr owns 2,166 shares of Intercept Pharmaceuticals Inc (ICPT) as of November 10, 2015, with a value of $41,154 and a weighting of 32.17%. Veitinger Klaus R Dr also owns 144,203 shares of Tricida Inc (TCDAQ) as of November 1, 2019, with a value of $1 and a weighting of 0%.

Latest Holdings of Veitinger Klaus R Dr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RLYP Relypsa Inc 2015-05-11 2,712 31.99 86,757
ICPT Intercept Pharmaceuticals Inc 2015-11-10 2,166 19.00 41,154
TCDAQ Tricida Inc 2019-11-01 144,203 0.00 1

Holding Weightings of Veitinger Klaus R Dr


Veitinger Klaus R Dr Form 4 Trading Tracker

According to the SEC Form 4 filings, Veitinger Klaus R Dr has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 5,834 shares on May 11, 2015, which brought Veitinger Klaus R Dr around $210,374.

According to the SEC Form 4 filings, Veitinger Klaus R Dr has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 1,000 shares on November 10, 2015, which brought Veitinger Klaus R Dr around $198,250.

According to the SEC Form 4 filings, Veitinger Klaus R Dr has made a total of 0 transactions in Tricida Inc (TCDAQ) over the past 5 years. The most-recent trade in Tricida Inc is the sale of 5,250 shares on November 1, 2019, which brought Veitinger Klaus R Dr around $204,120.

Insider Trading History of Veitinger Klaus R Dr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Veitinger Klaus R Dr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Veitinger Klaus R Dr Ownership Network

Ownership Network List of Veitinger Klaus R Dr

No Data

Ownership Network Relation of Veitinger Klaus R Dr

Insider Network Chart

Veitinger Klaus R Dr Owned Company Details

What does Tricida Inc do?

Who are the key executives at Tricida Inc?

Veitinger Klaus R Dr is the director of Tricida Inc. Other key executives at Tricida Inc include director & 10 percent owner Orbimed Advisors Llc , director & 10 percent owner David P Bonita , and 10 percent owner Venrock Healthcare Capital Partners Ii, L.p. .

Tricida Inc (TCDAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tricida Inc (TCDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tricida Inc (TCDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tricida Inc (TCDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tricida Inc Insider Transactions

No Available Data

Veitinger Klaus R Dr Mailing Address

Above is the net worth, insider trading, and ownership report for Veitinger Klaus R Dr. Currently GuruFocus does not have mailing address information for Veitinger Klaus R Dr.